참고문헌
- Health Insurance Review and Assessment Service [Internet]. Wonju: Health Insurance Review and Assessment Service; 2017 [cited 2017 May 16]. Available from: http://www.hira.or.kr.
- Global Initiative for Asthma. Global strategy for asthma management and prevention (updated 2017) [Internet]. Bethesda: Global Initiative for Asthma; 2017 [cited 2017 May 16]. Available from: http://www.ginasthma.org.
- Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 2002;110:58-64. https://doi.org/10.1067/mai.2002.125489
- Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007;120:1360-7. https://doi.org/10.1016/j.jaci.2007.09.019
- Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy 1996;26 Suppl 1:1-24.
- Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663-70. https://doi.org/10.1136/thx.2005.055699
- Peura S, Martikainen J, Klaukka T. Use and costs of asthma medication in 1980s. Publication M: 72. Helsinki: Social Insurance Institution; 1990.
- Klaukka T, Hirvonen A, Karhula K, Peura S. Good and bad news from asthma. Asthma barometer 2004. Suom Laakaril 2004;42:4002-4.
피인용 문헌
- Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model vol.23, pp.5, 2018, https://doi.org/10.1080/1354750x.2018.1443510
- Soluble CD93 in allergic asthma vol.10, pp.None, 2020, https://doi.org/10.1038/s41598-019-57176-2
- Challenges faced in managing adult asthma: A perspective from Asian countries vol.25, pp.12, 2017, https://doi.org/10.1111/resp.13935
- Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study vol.13, pp.6, 2017, https://doi.org/10.4168/aair.2021.13.6.945
- The nationwide retrospective cohort study by Health Insurance Review and Assessment Service proves that asthma management decreases the exacerbation risk of asthma vol.11, pp.1, 2017, https://doi.org/10.1038/s41598-021-81022-z
- Does the Use of Asthma-Controller Medication in Accordance with Guidelines Reduce the Incidence of Acute Exacerbations and Healthcare Costs? vol.85, pp.1, 2017, https://doi.org/10.4046/trd.2021.0087